Target intelligence / Profile preview

SPATA13 antisense RNA 1 (non-protein coding) (SPATA13-AS1)

Target
SPATA13-AS1
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein coding RNA)
01

Overview

SPATA13 antisense RNA 1 (SPATA13-AS1) is a long non-coding RNA located on chromosome 13q12.12 overlapping the SPATA13 gene. SPATA13-AS1 does not encode a protein but may regulate SPATA13 and thus influence cellular processes such as actin cytoskeleton dynamics and smooth muscle contraction. Genome-wide association studies have identified SPATA13-AS1 as a marker for variability in short-acting beta-agonist (SABA) bronchodilator response in asthma patients, particularly in African American populations. The specific molecular mechanisms are unconfirmed, but SPATA13-AS1 could act as a cis-regulatory element modulating SPATA13 expression, which itself is involved in guanine nucleotide exchange factor activity controlling Rho-family GTPases (Rac1, Cdc42). There are currently no documented direct drug interactions, established mechanisms of action for therapies, or safety concerns associated with SPATA13-AS1[1][2][3][4].

Other names
SPATA13 antisense RNA 1SPATA13-AS1SPATA13 antisense RNA 1 (non-protein coding)ENSG00000227213NCBI Gene ID: 100874231
02

Mechanism of action

Genetic variation in SPATA13-AS1 may regulate SPATA13 or related pathways, affecting response to bronchodilators; direct molecular mechanisms not experimentally established[4].

03

Biological functions

Regulator of gene expression (likely cis-regulation of SPATA13)Potential influence on airway smooth muscle contraction (by regulating SPATA13 expression)Other (role proposed, but not functionally confirmed)
04

Disease associations

Pharmacogenomic marker for asthma (bronchodilator response)Other
05

Safety considerations

None documented specifically for SPATA13-AS1[4].
06

Interacting drugs

Short-acting beta-agonists (SABA; e.g., albuterol) [association with drug response, not direct interaction]
07

Biomarkers

Genetic variants (SNPs) in SPATA13-AS1 associate with SABA response in African American and European American individuals with asthma[4].

Beyond the preview

Go deeper on SPATA13 antisense RNA 1 (non-protein coding) (SPATA13-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPATA13 antisense RNA 1 (non-protein coding) (SPATA13-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call